BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260417T080000
DTEND;TZID=America/Halifax:20260422T170000
DTSTAMP:20260503T180736
CREATED:20250717T213950Z
LAST-MODIFIED:20250717T214008Z
UID:10000219-1776412800-1776877200@oncodaily.com
SUMMARY:AACR Annual Meeting 2026
DESCRIPTION:The AACR Annual Meeting 2026 will take place from April 17–22 at the San Diego Convention Center in California\, bringing together the global cancer research community. \nOrganized by the American Association for Cancer Research\, this meeting serves as a key platform for scientists\, clinicians\, healthcare professionals\, patients\, and advocates to share the latest developments across all areas of cancer science and medicine. \nChaired by Paul S. Mischel from Stanford University and Alice T. Shaw from Dana-Farber Cancer Institute\, the program will feature research spanning population science\, prevention\, cancer biology\, translational and clinical studies\, as well as survivorship and advocacy. The AACR Annual Meeting offers participants valuable opportunities to learn\, collaborate\, and contribute to advancing progress in cancer care worldwide. \nMore posts featuring AACR on OncoDaily.com.
URL:https://oncodaily.com/event/aacr-annual-meeting-2026-331165
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, San Diego\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7269.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260218T080000
DTEND;TZID=America/Halifax:20260221T170000
DTSTAMP:20260503T180736
CREATED:20250717T130123Z
LAST-MODIFIED:20250717T130143Z
UID:10000220-1771401600-1771693200@oncodaily.com
SUMMARY:AACR IO Conference 2026
DESCRIPTION:The AACR IO Conference 2026\, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy\, will take place from February 18–21\, 2026\, at JW Marriott Los Angeles L.A. Live.  \nLed by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas\, the event will focus on cutting-edge research in cancer immunology\, highlighting breakthroughs in immuno-oncology (IO) drugs\, inflammatory modulators\, vaccines\, and cellular therapies. \nBuilding on the success of AACR IO 2025\, which drew over 600 participants\, AACR IO 2026 promises a comprehensive program including keynote lectures\, symposia\, spotlight sessions\, educational content\, and poster presentations. This forum offers a valuable opportunity for scientists\, clinicians\, industry leaders\, and advocates to engage with the latest advances in cancer immunotherapy. \nMore posts featuring AACR.
URL:https://oncodaily.com/event/aacr-io-conference-2026-331172
LOCATION:JW Marriott Los Angeles L.A. Live\, 900 W Olympic Blvd\, Los Angeles\, CA\, Los Angeles\, 90015\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/07/download-7.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250720T080000
DTEND;TZID=America/Halifax:20250725T170000
DTSTAMP:20260503T180736
CREATED:20250323T161410Z
LAST-MODIFIED:20250607T192916Z
UID:10000188-1752998400-1753462800@oncodaily.com
SUMMARY:The AACR Integrative Molecular Epidemiology Workshop
DESCRIPTION:The AACR Integrative Molecular Epidemiology Workshop will be held from July 20 – 25\, 2025 at Philadelphia\, Pennsylvania.\nThe AACR Integrative Molecular Epidemiology Workshop is a week-long program designed to enhance the skills of early-career researchers in molecular cancer epidemiology. It bridges disciplines like epidemiology\, bioinformatics\, and molecular biology\, offering hands-on experience with omics technologies and study design. \nThe workshop focuses on practical applications\, reproducibility\, and overcoming barriers to cancer health equity\, including diversity in clinical trials. \nTargeted at emerging researchers and clinicians\, the workshop fosters technical expertise and interdisciplinary collaboration\, shaping the future of cancer research and cultivating a diverse biomedical workforce. \nApplication deadline for the event is April 10th\, 2025. \nRead more about AACR at OncoDaily.com.
URL:https://oncodaily.com/event/aacr259494
LOCATION:Bellevue Hotel\, 200 S Broad St\, Philadelphia\, Philadelphia\, 19102
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/03/Screenshot-from-2025-03-18-15-34-52.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20250617T000000
DTEND;TZID=Europe/Helsinki:20250621T000000
DTSTAMP:20260503T180736
CREATED:20241015T184001Z
LAST-MODIFIED:20250607T193343Z
UID:10000036-1750118400-1750464000@oncodaily.com
SUMMARY:18th International Conference on Malignant Lymphoma (ICML)
DESCRIPTION:AACR is thrilled to be partnering for the 18th International Conference on Malignant Lymphoma (ICML)\, which will take place in Lugano from June 17-21\, 2025. \nThis conference is expected to draw thousands of physicians and researchers from nearly 100 countries. As the premier global event on malignant lymphomas\, ICML will showcase the latest advancements in the diagnosis and treatment of all types of lymphatic system tumors. In 2023\, the conference attracted 4\,000 attendees\, underscoring its significance in the field. \nFor more information\, visit the ICML website and start planning to attend.
URL:https://oncodaily.com/event/165569
LOCATION:Palazzo dei Congressi\, piazza dell' Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-114.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250204T000000
DTSTAMP:20260503T180736
CREATED:20241217T163617Z
LAST-MODIFIED:20250608T082009Z
UID:10000106-1738368000-1738627200@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer
DESCRIPTION:AACR Special Conference in Cancer Research: DNA Methylation\, Clonal Hematopoiesis\, and Cancer will be held from February 1-4\, 2025. \nThe upcoming AACR Special Conference\, chaired by Stephen Baylin\, Margaret Goodell\, and Peter Jones will focus on the pivotal role of DNA methylation in human cancer\, celebrating the 25th Anniversary of the groundbreaking 1999 AACR Special Conference on “DNA Methylation\, Imprinting\, and the Epigenetics of Cancer.” This conference aims to spotlight recent research advances in the field of DNA methylation\, which has emerged as a central mechanism in cancer biology. It will emphasize the significance of DNA methylation specifically\, rather than covering broader chromatin biology topics like histone modifications. \nThe conference will provide extensive opportunities for presentation\, particularly for highly-rated abstracts\, with podium presentations\, plenary sessions\, and “lightning” talks scheduled before each poster session. Researchers\, clinicians\, and scientists will gather in San Diego for this exciting event\, which promises to offer valuable insights into the molecular underpinnings of cancer and the therapeutic potential of DNA methylation-based approaches. \nAdvance Registration Deadline is December 20th. \n 
URL:https://oncodaily.com/event/207579
LOCATION:The Westin San Diego Gaslamp Quarter\, 910 Broadway Cir\, San Diego\, CA\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Ge77HYoXIAAo0Tj.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250201T000000
DTEND;TZID=America/Halifax:20250203T000000
DTSTAMP:20260503T180736
CREATED:20241206T195928Z
LAST-MODIFIED:20250608T082016Z
UID:10000094-1738368000-1738540800@oncodaily.com
SUMMARY:13th AACR-JCA Joint Conference
DESCRIPTION:13th AACR-JCA Joint Conference will be held from February 1-3\, 2025 at Maui\, Hawaii. \nThe 13th AACR-JCA Joint Conference is a significant event hosted by the American Association for Cancer Research (AACR) in collaboration with the Japanese Cancer Association (JCA). This conference has a longstanding tradition of bringing together top cancer researchers from the United States\, Japan\, and around the world to share groundbreaking findings and discuss the latest advancements in basic\, translational\, and clinical cancer research. \nThe event aims to foster both formal and informal interactions among scientists and healthcare professionals\, promoting international collaborations in the field of cancer research. It provides a unique platform for investigators at all career stages to engage with the most current research developments\, share ideas\, and collaborate on new approaches to cancer treatment and prevention. \nJust like its previous editions\, the conference will present a comprehensive overview of contemporary cancer research\, addressing critical issues across various disciplines. Participants can expect to explore cutting-edge topics\, exchange knowledge\, and expand their networks\, contributing to the advancement of cancer research globally. \nRegistration is Open until December 20\, 2024.
URL:https://oncodaily.com/event/199008
LOCATION:Hyatt Regency Maui\, 200 Nohea Kai Dr\, Lahaina\, HI\, Maui\, Hawaii\, 96761\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/12/Screenshot-260-e1733515086197.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250121T130000
DTEND;TZID=America/Halifax:20250121T143000
DTSTAMP:20260503T180736
CREATED:20250111T200927Z
LAST-MODIFIED:20250608T082110Z
UID:10000116-1737464400-1737469800@oncodaily.com
SUMMARY:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR
DESCRIPTION:Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21\, 2025\, Virtually. \nThe forum will explore the new generation of patient-centric cancer clinical trials\, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer\, largely due to clinical trials\, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient\, inclusive\, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes. \nThe upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California\, San Francisco\, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso\, DO\, PhD (HC)\, FAACR\, from Yale Cancer Center\, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson\, MD\, PhD\, FAACR\, from CSHL Cancer Center\, will highlight the Cancer Therapeutics Initiative\, which focuses on translating basic research into clinical applications. Laura van ‘t Veer\, PhD\, from the University of California\, San Francisco\, will present on the second-generation design of the I-SPY 2 trial\, driving advancements in precision medicine. These experts will cover a broad range of topics\, all geared toward advancing cancer clinical trials and patient care. \nRegister Now!
URL:https://oncodaily.com/event/221654
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/1736108582473-e1736625939487.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241023T000000
DTEND;TZID=Europe/Helsinki:20241025T000000
DTSTAMP:20260503T180736
CREATED:20241017T182233Z
LAST-MODIFIED:20250608T081055Z
UID:10000047-1729641600-1729814400@oncodaily.com
SUMMARY:36th EORTC-NCI-AACR Symposium
DESCRIPTION:36th EORTC-NCI-AACR Symposium will be held at Barcelona\, Spain from October 23-25\, 2024. \nHosted by the European Organisation for Research and Treatment of Cancer (EORTC)\, the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR)\, the 2024 Symposium attracts academics\, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development\, target selection and the impact of new discoveries in molecular biology. \nENA 2024 stands as the drug development and translational research meeting\, giving the spotlight to preclinical and phase I studies\, ensuring in-depth scientific discussions on the latest developments in targets and drugs. \nFor Registration Visit Here
URL:https://oncodaily.com/event/166975
LOCATION:Centre de convencions internacional Bacerlona\, Plaça de Willy Brandt\, 11-14\, Barcelona\, 08019\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ENA_900x400-1.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
END:VCALENDAR